ADAM17 and Miyoshi myopathy: Although the research in MM was limited, the existing evidence suggests that ADAM17 may be involved in the pathological process of the disease.<h4>Methods</h4>In this study, the serum ADAM17 concentrations of 26 MM patients at three different clinical stages (newly diagnosed, remission and progression) were detected by ELISA, and the correlation between ADAM17 concentrations and clinical parameters was analyzed.